Calcitonin gene-related peptide antagonist therapy and migraines.

Andrew Zolp

JAAPA : official journal of the American Academy of Physician Assistants 2022 May 01

filter terms:

all
compound
show more »
show less «

Calcitonin gene-related peptide antagonists are a novel new class of medications that have been shown to reduce migraine headache pain and bothersome symptoms in patients who have had an insufficient response to triptans or for whom triptans are contraindicated. This article describes the new medications. Copyright © 2022 American Academy of Physician Associates.

Citation

Andrew Zolp. Calcitonin gene-related peptide antagonist therapy and migraines. JAAPA : official journal of the American Academy of Physician Assistants. 2022 May 01;35(5):19-20